Dakota15
Senior Member (Voting Rights)
1/23/25: 'East Alabama Health partners with Duke, NIH to study Long COVID Treatments'
As part of the NIH’s RECOVER initiative, Drs. Nathan Douthit and Haley Clay are conducting clinical trials to test the safety and effectiveness of two potential treatments for patients with Long COVID.
“We are involved in the RECOVER-Autonomic arm, which means we are looking at the autonomic symptoms of Long COVID such as fast heart rate, dizziness, and fatigue,” said Dr. Douthit, principal investigator and director of EAMC’s Internal Medicine Residency Program. “I am excited to see what therapies develop as a result of this study and expand our knowledge of treatment for this condition.”
As part of the NIH’s RECOVER initiative, Drs. Nathan Douthit and Haley Clay are conducting clinical trials to test the safety and effectiveness of two potential treatments for patients with Long COVID.
“We are involved in the RECOVER-Autonomic arm, which means we are looking at the autonomic symptoms of Long COVID such as fast heart rate, dizziness, and fatigue,” said Dr. Douthit, principal investigator and director of EAMC’s Internal Medicine Residency Program. “I am excited to see what therapies develop as a result of this study and expand our knowledge of treatment for this condition.”